Home / Cancer and immune system / Bicalutamide
ATC L02BB03 · Endocrine Therapy
Bicalutamide shortage
As of 31 Oct 2026, Bicalutamide has a reported shortage in 3 of the 5 countries we track (Italy, Austria, Belgium), covering 6 products.
Countries3/5
Products6packs or presentations
Short since1 Oct 202513 months ago
Earliest return30 Nov 2026company estimate
No return date5products
Main reasonIncreased demand
Timeline
ItalyAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | BICALUTAMIDE EG STADA | EG S.P.A. | 1 Oct 2025 | not given | Increased demand Elevata richiesta |
| IT | BICALUTAMIDE AHCL | ACCORD HEALTHCARE, S.L.U. | 24 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | BICALUTAMIDE RATIOPHARM | RATIOPHARM GMBH | 1 Jul 2026 | not given | Increased demand Elevata richiesta |
| IT | BICALUTAMIDE AUROBINDO | Eugia Pharma (Malta) Limited | 22 Jul 2026 | not given | Increased demand Elevata richiesta |
| AT | Bicalutamid-ratiopharm 150 mg Filmtabletten, 90 Stück | Teva B.V. | 11 May 2026 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| BE | Casodex 50 mg (PI Pharma) film-coat. tabl. 28 | PI Pharma | 6 Aug 2026 | 30 Nov 2026 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.